| 5015663 |
Treatment of conditions requiring enhanced oxygen availability of mammalian tissues |
John T. Suh, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber |
1991-05-14 |
| 4948582 |
Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
John T. Suh, Charles E. Pendley, II, Kin T. Yu, Paul R. Menard, Alain B. Schreiber |
1990-08-14 |
| 4849416 |
Treatment of conditions requiring enhanced oxygen availability to mammalian tissues |
Charles E. Pendley, II, John T. Suh, Kin T. Yu, Paul R. Menard, Tihamer Herczeg |
1989-07-18 |
| 4673680 |
.alpha..sub.2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility |
— |
1987-06-16 |
| 4352809 |
Method of producing alpha.sub.2 antagonism |
William E. Bondinell, Robert M. DeMarinis, Jacob P. Hieble |
1982-10-05 |
| 4228170 |
7- and/or 8-Sulfur substituted 1,2,3,4-tetrahydroisoquinoline compounds |
William E. Bondinell |
1980-10-14 |
| 4218464 |
4- and 5-Substituted 2,3-dihydro-1H-isoindoles, pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase |
William E. Bondinell |
1980-08-19 |
| 4208430 |
Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase |
William E. Bondinell |
1980-06-17 |
| 4192888 |
Pharmaceutical compositions and method of inhibiting phenylethanolamine N-methyltransferase |
William E. Bondinell |
1980-03-11 |